trial · primary record
Nemtabrutinib
Chronic Lymphocytic Leukemia
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2031-12-01 |
| Primary endpoint | Overall response rate (ORR) |
| Registry ID | NCT07796373 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:21.030Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07796373
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.